95-3818. Manufacturer of Controlled Substances; Notice of Registration  

  • [Federal Register Volume 60, Number 32 (Thursday, February 16, 1995)]
    [Notices]
    [Page 9053]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 95-3818]
    
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF JUSTICE
    Drug Enforcement Administration
    
    
    Manufacturer of Controlled Substances; Notice of Registration
    
        By Notice dated March 18, 1994, and published in the Federal 
    Register on March 28, 1994, (59 FR 14426), and by Notice dated May 6, 
    1994, and published in the Federal Register on May 13, 1994, (59 FR 
    25126), Mallinckrodt, Specialty Chemical Company, Mallinckrodt & Second 
    Streets, St. Louis, Missouri 63147, made application to the Drug 
    Enforcement Administration (DEA) to be registered as a bulk 
    manufacturer of the basic classes of controlled substances listed 
    below:
    
    ------------------------------------------------------------------------
                                Drug                               Schedule 
    ------------------------------------------------------------------------
    Tetrahydrocannabinols (7370)................................  I         
    Methylphenidate (1724)......................................  II        
    Cocaine (9041)..............................................  II        
    Codeine (9050)..............................................  II        
    Diprenorphine (9058)........................................  II        
    Etorphine Hydrochloride (9050)..............................  II        
    Dihydrocodeine (9120).......................................  II        
    Ocycodone (9143)............................................  II        
    Hydromorphone (9150)........................................  II        
    Diphenoxylate (9170)........................................  II        
    Diphenoxylate (9170)........................................  II        
    Benzoylecogonine (9180).....................................  II        
    Hydrocodone (9193)..........................................  II        
    Levorphanol (9220)..........................................  II        
    Meperidine (9230)...........................................  II        
    Methadone (9250)............................................  II        
    Methadone-intermediate (9254)...............................  II        
    Dextropropoxyphene, bulk (non-dosage forms) (9273)..........  II        
    Morphine (9300).............................................  II        
    Thebaine (9333).............................................  II        
    Opium extracts (9610).......................................  II        
    Opium fluid extract (9620)..................................  II        
    Opium tincture (9630).......................................  II        
    Opium powdered (9639).......................................  II        
    Opium granulated (9640).....................................  II        
    Oxymorphone (9652)..........................................  II        
    Alfentanil (9737)...........................................  II        
    Sufentanil (9740)...........................................  II        
    Fentanyl (9801).............................................  II        
    ------------------------------------------------------------------------
    
        A registered manufacturer did file a written request for a hearing 
    with respect to Methylphenidate. Therefore, pursuant to Section 303 of 
    the Comprehensive Drug Abuse Prevention and Control Act of 1970 and 
    Title 21, code of Federal Regulations, Section 1301.54(e), Deputy 
    Assistant Administrator, Office of Diversion Control, hereby orders 
    that the application submitted by the above firm for registration as a 
    bulk manufacturer of the basic classes of controlled substances listed 
    above is granted with the exception of Methylphenidate.
    
        Dated: February 6, 1995.
    Gene R. Haislip,
    Deputy Assistant Administrator, Office of Diversion Control, Drug 
    Enforcement Administration.
    [FR Doc. 95-3818 Filed 2-15-95; 8:45 am]
    BILLING CODE 4410-09-M
    
    

Document Information

Published:
02/16/1995
Department:
Drug Enforcement Administration
Entry Type:
Notice
Document Number:
95-3818
Pages:
9053-9053 (1 pages)
PDF File:
95-3818.pdf